PT100691A - Intermediarios de fosforos modificados para fornecer grupos funcionais na extremidade 5' dos oligonucleotidos - Google Patents

Intermediarios de fosforos modificados para fornecer grupos funcionais na extremidade 5' dos oligonucleotidos

Info

Publication number
PT100691A
PT100691A PT100691A PT10069192A PT100691A PT 100691 A PT100691 A PT 100691A PT 100691 A PT100691 A PT 100691A PT 10069192 A PT10069192 A PT 10069192A PT 100691 A PT100691 A PT 100691A
Authority
PT
Portugal
Prior art keywords
carbon atoms
group
oligonucleotide
atoms
oligonucleotidos
Prior art date
Application number
PT100691A
Other languages
English (en)
Other versions
PT100691B (pt
Inventor
Michael J Conrad
Douglas A Livingston
David S Jones
John P Hachmann
Stephen Coutts
Original Assignee
Jolla Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Pharma filed Critical Jolla Pharma
Publication of PT100691A publication Critical patent/PT100691A/pt
Publication of PT100691B publication Critical patent/PT100691B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2408—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyalkyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
PT100691A 1991-07-15 1992-07-15 Intermediarios de fosforos modificados para fornecer grupos funcionais na extremidade 5' dos oligonucleotidos PT100691B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73105591A 1991-07-15 1991-07-15

Publications (2)

Publication Number Publication Date
PT100691A true PT100691A (pt) 1993-10-29
PT100691B PT100691B (pt) 1999-06-30

Family

ID=24937868

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100691A PT100691B (pt) 1991-07-15 1992-07-15 Intermediarios de fosforos modificados para fornecer grupos funcionais na extremidade 5' dos oligonucleotidos

Country Status (12)

Country Link
EP (1) EP0523978B1 (pt)
JP (3) JP2899111B2 (pt)
AT (1) ATE179982T1 (pt)
AU (3) AU664184B2 (pt)
CA (1) CA2073846C (pt)
DE (1) DE69229149T2 (pt)
DK (1) DK0523978T3 (pt)
ES (1) ES2131060T3 (pt)
GR (1) GR3030260T3 (pt)
IE (1) IE922292A1 (pt)
PT (1) PT100691B (pt)
WO (1) WO1993002093A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
IE922292A1 (en) 1991-07-15 1993-01-27 Jolla Pharma Modified phosphorous intermediates for providing functional¹groups on the 5' end of oligonucleotides
KR100361933B1 (ko) 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
AU2003200284B2 (en) * 1998-03-27 2006-11-02 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
ATE313548T1 (de) * 1998-06-22 2006-01-15 Affymetrix Inc Reagenz und verfahren zu fester phase synthese
US6399578B1 (en) 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US6458953B1 (en) 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
CN1399562A (zh) 1999-11-28 2003-02-26 拉卓拉药物公司 基于抗体亲和力来治疗狼疮的方法及使用这种方法的筛选方法和组合物
DE10013600A1 (de) * 2000-03-18 2002-01-10 Aventis Res & Tech Gmbh & Co Reaktive Monomere für die Oligonucleotid- und Polynucleotidsynthese, modifizierte Oligonucleotide und Polynucleotiden und ein Verfahren zu deren Herstellung
KR100985457B1 (ko) 2001-06-21 2010-10-06 다이나박스 테크놀로지 코퍼레이션 키메라 면역조절 화합물 및 그것들의 사용 방법
DE10163836A1 (de) * 2001-12-22 2003-07-10 Friz Biochem Gmbh Multifunktionales Reagenz zur Synthese von thiolmodifizierten Oligomeren
JP4495670B2 (ja) * 2005-12-27 2010-07-07 三井化学株式会社 メルカプトアルキルホスホニウム化合物の製造法
CN102712696A (zh) 2009-09-16 2012-10-03 弗·哈夫曼-拉罗切有限公司 包含卷曲螺旋和/或系链的蛋白质复合体及其用途
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
EP2655413B1 (en) 2010-12-23 2019-01-16 F.Hoffmann-La Roche Ag Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
CN103384681B (zh) 2010-12-23 2018-05-18 霍夫曼-拉罗奇有限公司 结合剂
EP2659269B1 (en) 2010-12-23 2016-10-26 Roche Diagniostics GmbH Detection of a posttranslationally modified polypeptide by a bi-valent binding agent
MX2014009565A (es) 2012-02-10 2014-11-10 Genentech Inc Anticuerpos monocatenarios y otros heteromultimeros.
FR2989086B1 (fr) 2012-04-04 2017-03-24 Centre Nat De La Rech Scient (Cnrs) Composes thiol et leur utilisation pour la synthese d'oligonucleotides modifies
FR2989089B1 (fr) * 2012-04-04 2020-02-07 Etablissement Francais Du Sang Oligonucleotides modifies comprenant des fonctions thiol et leur utilisation pour la detection d'acides nucleiques
ES2597228T3 (es) 2012-06-27 2017-01-17 F. Hoffmann-La Roche Ag Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas
KR20150030744A (ko) 2012-06-27 2015-03-20 에프. 호프만-라 로슈 아게 표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Fc-영역 접합체의 제조 방법 및 그의 용도
EP2928877B1 (en) * 2012-12-06 2020-01-22 Merck Sharp & Dohme Corp. Disulfide masked prodrug compositions and methods
WO2016087416A1 (en) 2014-12-03 2016-06-09 F. Hoffmann-La Roche Ag Multispecific antibodies
JP2022535717A (ja) 2019-05-24 2022-08-10 エンピリコ インク. アンジオポエチン様7(angptl7)関連疾患の処置
US20250197859A1 (en) * 2022-03-28 2025-06-19 Empirico Inc. Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases
EP4499834A2 (en) * 2022-03-28 2025-02-05 Empirico Inc. Modified oligonucleotides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3225063A (en) * 1962-05-21 1965-12-21 Scott Paper Co Organic cyclic carbonates
US4191668A (en) * 1977-02-03 1980-03-04 Scripps Clinic And Research Foundation Induction of immunological tolerance
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4650675A (en) * 1983-08-18 1987-03-17 The Children's Medical Center Corporation Oligonucleotide conjugates
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
US4575558A (en) * 1984-02-15 1986-03-11 American Hospital Supply Corporation Preparation of optically active 1,3-dioxolane-4-methanol compounds
US4751181A (en) * 1984-12-31 1988-06-14 Duke University Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
AU6593386A (en) * 1985-10-24 1987-05-19 Research Corp. Ltd. Biochemical reagent
DE3811005A1 (de) * 1988-03-31 1989-10-19 Bayer Ag Thionophosphor(phosphon)saeureamidester
EP0354323A3 (en) * 1988-08-12 1990-06-13 American Cyanamid Company Antidiabetic phosphates
DE3916871A1 (de) * 1989-05-24 1990-11-29 Boehringer Mannheim Gmbh Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren
ES2060184T3 (es) * 1989-06-22 1994-11-16 Atta Moleculas anfifilicas conteniendo fluor y fosforo con propiedades tensoactivas.
DE3937116A1 (de) * 1989-11-03 1991-05-08 Dainippon Ink & Chemicals Verfahren zur herstellung cyclocarbonathaltiger ester
IE922292A1 (en) 1991-07-15 1993-01-27 Jolla Pharma Modified phosphorous intermediates for providing functional¹groups on the 5' end of oligonucleotides

Also Published As

Publication number Publication date
IE922292A1 (en) 1993-01-27
DK0523978T3 (da) 1999-11-01
HK1014369A1 (en) 1999-09-24
ATE179982T1 (de) 1999-05-15
AU4520297A (en) 1998-02-19
AU703715B2 (en) 1999-04-01
ES2131060T3 (es) 1999-07-16
JP2899111B2 (ja) 1999-06-02
JP3188243B2 (ja) 2001-07-16
DE69229149D1 (de) 1999-06-17
AU1968592A (en) 1993-01-21
EP0523978B1 (en) 1999-05-12
GR3030260T3 (en) 1999-08-31
PT100691B (pt) 1999-06-30
AU686911B2 (en) 1998-02-12
JPH07500576A (ja) 1995-01-19
WO1993002093A1 (en) 1993-02-04
JP3488435B2 (ja) 2004-01-19
CA2073846C (en) 2007-09-18
AU664184B2 (en) 1995-11-09
CA2073846A1 (en) 1993-01-16
JPH11228592A (ja) 1999-08-24
JP2001302684A (ja) 2001-10-31
AU4058095A (en) 1996-03-14
DE69229149T2 (de) 1999-12-09
EP0523978A1 (en) 1993-01-20

Similar Documents

Publication Publication Date Title
ES2131060T3 (es) Intermedios modificados que contienen fosforo para proporcionar grupos funcionales en el extremo 5' de oligonucleotidos.
BR9102108A (pt) Composicao de resina epoxi,composicao util para a cura de um poliepoxi ou resina epoxi de peso molecular modificado,catalisador latente,processo para revestir artigos e metodo para ajustar o tempo de gel de uma composicao
PT83236B (pt) Processo para a preparacao de uma composicao polimerica de dissulfureto modificado
ATE88338T1 (de) Vernetzungsmittel zur haarbehandlung.
PT869987E (pt) Composicao que contem uma poliamida e processo para a sua fabricacao
FI946157A0 (fi) Polyaminoituja ligandeja ja niiden metallikompleksPolyaminoituja ligandeja ja niiden metallikomplekseja eja
DE3650760D1 (de) Polynukleotide und Proben mit Verwendung in Nukleinsäure-Sandwichassay in Lösungsphase
ES2193165T3 (es) Composiciones de revestimiento endurecibles que contienen aditivos de carbamato.
PT775155E (pt) Derivados de estra-1,3,5(10)-trieno processo para a sua preparacao e composicoes farmaceuticas que contem estes compostos
PT91602A (pt) Processo para a preparacao de compostos espiro com accao antibacteriana e de composicoes farmaceuticas que os contem
DE68904995D1 (de) Phenolische thioaether, deren herstellung und verwendung.
KR927003693A (ko) 폴리아민-작용성 실란 수지
DK0740679T3 (da) Tværbundne polymere ammoniumsalte
BR0102243A (pt) Processo para a preparação de dissulfetos orgânicos, e, uso do dissulfeto orgânico
DE69318628D1 (de) Aus einem Pflanzenöl und einer Zusatzkonditionierung zusammengesetztes Zweitaktzyklusschmiermittel
MX9304293A (es) Metodo para curar cauchos sin la formacion de nitrosaminas.
DK396989A (da) Cycliske svovlforbindelser
FR2742144B1 (fr) Procede de preparation de disulfures et de polysulfures organiques en presence de resines polystyrene-divinylbenzene possedant des groupes amine primaire
ES2115722T3 (es) Compuestos de benzaldehido anticancerosos.
ES533855A0 (es) Procedimiento para preparar n-(1,3-ditiolan-2-ilideno) anilinas
BR9713798A (pt) Composição de agente de cura, e, composição epóxi de dois componentes a base de solventes ou isenta de solventes.
ES2073848T5 (es) Agente aglutinante endurecible y procedimiento para su preparacion.
KR900701747A (ko) 아미노아세토니트릴 유도체
ATE23341T1 (de) Phosphorderivate von carbamimidothioischen saeureestern.
ATE101145T1 (de) Organische verbindungen und ihre verwendung als pharmazeutika.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930421

FG3A Patent granted, date of granting

Effective date: 19990316

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20100916